Sugammadex: cyclodextrins, development of selective binding agents, pharmacology, clinical development, and future directions

Anesthesiol Clin. 2010 Dec;28(4):691-708. doi: 10.1016/j.anclin.2010.08.014.

Abstract

Neuromuscular blocking agents are widely used in perioperative medicine to aid in endotracheal intubation, facilitate surgery, and in critical care/emergency medicine settings. Muscle relaxants have profound clinical uses in current surgical and intensive care and emergency medical therapy. This article reviews cyclodextrins, development of selective binding agents, clinical development, and future directions of sugammadex.

Publication types

  • Review

MeSH terms

  • Animals
  • Clinical Trials as Topic
  • Cyclodextrins / pharmacology
  • Dose-Response Relationship, Drug
  • Drug Approval
  • Humans
  • Neuromuscular Blockade*
  • Neuromuscular Blocking Agents / metabolism*
  • Sugammadex
  • United States
  • United States Food and Drug Administration
  • gamma-Cyclodextrins / chemistry
  • gamma-Cyclodextrins / pharmacology
  • gamma-Cyclodextrins / therapeutic use*

Substances

  • Cyclodextrins
  • Neuromuscular Blocking Agents
  • gamma-Cyclodextrins
  • Sugammadex